1671 related articles for article (PubMed ID: 33295032)
21. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
[TBL] [Abstract][Full Text] [Related]
22. Aclidinium bromide for stable chronic obstructive pulmonary disease.
Ni H; Soe Z; Moe S
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
[TBL] [Abstract][Full Text] [Related]
23. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
25. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Frei A; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010257. PubMed ID: 30371937
[TBL] [Abstract][Full Text] [Related]
26. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Pavord ID; Chanez P; Criner GJ; Kerstjens HAM; Korn S; Lugogo N; Martinot JB; Sagara H; Albers FC; Bradford ES; Harris SS; Mayer B; Rubin DB; Yancey SW; Sciurba FC
N Engl J Med; 2017 Oct; 377(17):1613-1629. PubMed ID: 28893134
[TBL] [Abstract][Full Text] [Related]
27. Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease.
Yang IA; Ferry OR; Clarke MS; Sim EH; Fong KM
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD002991. PubMed ID: 36971693
[TBL] [Abstract][Full Text] [Related]
28. Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
Pavord ID; Chapman KR; Bafadhel M; Sciurba FC; Bradford ES; Schweiker Harris S; Mayer B; Rubin DB; Yancey SW; Paggiaro P
Int J Chron Obstruct Pulmon Dis; 2021; 16():1755-1770. PubMed ID: 34163157
[TBL] [Abstract][Full Text] [Related]
29. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary rehabilitation versus usual care for adults with asthma.
Osadnik CR; Gleeson C; McDonald VM; Holland AE
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013485. PubMed ID: 35993916
[TBL] [Abstract][Full Text] [Related]
31. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
[TBL] [Abstract][Full Text] [Related]
32. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
33. Systemic treatments for eczema: a network meta-analysis.
Sawangjit R; Dilokthornsakul P; Lloyd-Lavery A; Lai NM; Dellavalle R; Chaiyakunapruk N
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013206. PubMed ID: 32927498
[TBL] [Abstract][Full Text] [Related]
34. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
35. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.
Howcroft M; Walters EH; Wood-Baker R; Walters JA
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005074. PubMed ID: 27990628
[TBL] [Abstract][Full Text] [Related]
36. Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.
Threapleton CJ; Janjua S; Fortescue R; Baker EH
Cochrane Database Syst Rev; 2019 May; 5(5):CD013024. PubMed ID: 31125127
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
38. Intermittent prophylactic antibiotics for bronchiectasis.
Spencer S; Donovan T; Chalmers JD; Mathioudakis AG; McDonnell MJ; Tsang A; Leadbetter P
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013254. PubMed ID: 34985761
[TBL] [Abstract][Full Text] [Related]
39. Sublingual immunotherapy for asthma.
Fortescue R; Kew KM; Leung MST
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
[TBL] [Abstract][Full Text] [Related]
40. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]